Skip to main content
. 2018 Jan 30;115(7):E1511–E1519. doi: 10.1073/pnas.1716452115

Fig. 2.

Fig. 2.

Loss of Cic in hematopoietic cells causes T cell acute lymphoblastic leukemia/lymphoma (T-ALL). (A) Tumor-free survival for Tek-cre; Cicflox/flox mice and control mice. The median survival age was 49.2 wk for the Tek-cre; Cicflox/flox mice. (B) In the bone marrow transplantation study, wild-type mice that received donor cells from the UBC-cre/ERT2; Cicflox/flox mice and treated with tamoxifen (TAM) showed reduced tumor-free survival (median survival = 26.6 wk posttamoxifen treatment). (C) Flow cytometry analysis of the thymus from wild-type mice received donor cells from the control Cicflox/flox mice, and tumors from two wild-type mice received donor cells from the UBC-cre/ERT2; Cicflox/flox mice. Upper panels depict percentage of donor-derived cells (CD45.2+).